Law Firm Confirms Health Risks For Women Raised By FDA Med Alert
On October 20, the FDA issued a Med Alert to physicians and healthcare providers that cites serious complications from vaginal slings. This is a class of product marketed to treat stress urinary incontinence, a condition estimated to affect as many as 14 million women across the nation. Vaginal slings are constructed with surgical mesh designed to reinforce weakened bladder and urethra muscles that involuntarily release urine during moments of physical stress.
The law firm of Blasingame, Burch, Garrard & Ashley of Athens, Georgia, is handling the largest number of lawsuits in the country related to vaginal sling injuries. At present, they represent plaintiffs, with cases in Georgia, Florida, Oklahoma, Maryland, New Jersey, Ohio, and Missouri. They are investigating numerous cases in several other states. All of these cases involve injuries from vaginal slings that were implanted to correct stress urinary incontinence.
The lawsuits allege that the device's construction was defective and that it caused serious injuries, including erosion of vaginal tissues. Other conditions and injuries experienced include chronic pain, infections, abscesses, bloody discharges, and impaired sexual functionality. Some of the plaintiffs have had to undergo multiple surgeries. These injuries are similar to those reported by the FDA in the Med Alert.
"Sling manufacturers represented this device to the FDA and physicians as effective and fit for use with patients. The FDA's recent alert supports what we have become fully aware of in the course of talking with numerous plaintiffs seriously injured by vaginal slings -- that there has been a great need for both physicians and patients to understand the symptoms and potential injuries from implantation of this type of device," explains Attorney Henry Garrard III.